Replimune said the agency had issued a complete response letter regarding the company’s biologics license application for RP1 ...

"REPL BREAKING NEWS: Replimune Group, Inc. Stock Plummets 75% After FDA Response Letter -- BFA Law Announces Securities Fraud Investigation And Urges Investors To Contact The Firm >REPL" was published ...

Replimune stock fell after the FDA rejected its RP1 application, citing flaws in the trial design and lack of substantial evidence for approval.

Replimune (REPL) stock rebounds even as FDA rejection of its RP1 skin cancer drug lead to multiple analyst downgrades on Wall Street. Read more here.

Replimune (REPL) stock plummeted on Tuesday after the biotechnology company received a Complete Response Letter (CRL) from ...

Replimune Group (NASDAQ:REPL – Get Free Report) ‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Thursday, Benzinga reports ...

Shares of Centene cratered Wednesday, a day after the giant managed-care provider withdrew its full-year outlook after receiving new data about enrollments and the health of those covered ...

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) for ...

Centene pulled its financial outlook for the rest of the year after learning that enrollees in its Affordable Care Act plans got more health care than expected.

Stock Market Plummets as Trump Announces Tariffs Start Date Donald Trump is back at it with his haphazard tariff announcements.

QuantumScape stock surged 75% this week following the company’s announcement of a breakthrough in manufacturing. The recent advancement with the Cobra separator signifies more than just a ...